1. 8 A prospective longitudinal follow up study using T1 and T2 mapping sequences and twelve-segment myocardial assessment to identify and monitor myocardial inflammation in myositis. (March 2019) Authors: Bromage, D; Nabeebaccus, A; O'gallagher, K; Le, K; Pearce, L; Millin, A; Kellman, P; Gordon, P; Sado, D Journal: Heart Issue: Volume 105(2019)Supplement 3 Page Start: A7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O-233 Micronized progesterone plus dydrogesterone versus micronized progesterone alone for luteal phase support in frozen-thawed cycles: a prospective cohort study. (6th August 2021) Authors: Ho, T; Pham, T; Le, K; Ly, T; Le, H; Nguyen, D; Ho, V; Dang, V; Phung, T; Norman, R; Mol, B; Vuong, L Journal: Human reproduction Issue: Volume 36:Supplement 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP24 Neutralising antibody potency against SARS-CoV-2 wild-type and Omicron BA.1 and BA.4/5 variants in infliximab and vedolizumab treated patients with Inflammatory Bowel Disease after three doses of COVID-19 vaccine: a prospective multicentre cohort study. (30th January 2023) Authors: Liu, Z; Le, K; Zhou, X; Alexander, J; Lin, S; Bewshea, C; Chanchlani, N; Nice, R; McDonald, T; Lamb, C; Sebastian, S; Kok, K; Lees, C; Hart, A; Pollok, R; Boyton, R; Altmann, D; Pollock, K; Goodhand, J; Kennedy, N Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P535 COVID-19 vaccine-induced neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 are diminished in patients with inflammatory bowel disease on anti-TNF or JAK-inhibitor therapy. (30th January 2023) Authors: Liu, Z; Alexander, J; Le, K; Zhou, X; Ibraheim, H; Anandabaskaran, S; Saifuddin, A; Lin, K; Mcfarlane, L; Anand, N; Constable, L; Castro-Seoane, R; Nice, R; Bewshea, C; D'Mello, A; Jones, G R; Balarajah, S; Fiorentino, F; Sebastian, S; Irving, P Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PL3.1 A phase 1, open-label, perioperative study of ivosidenib (AG-120) and vorasidenib (AG-881) in recurrent, IDH1-mutant, low-grade glioma: results from cohort 1. (6th September 2019) Authors: Mellinghoff, I K; Wen, P Y; Taylor, J W; Maher, E A; Arrillaga-Romany, I; Peters, K B; Le, K; Tai, F; Steelman, L; Cloughesy, T F Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Regulation of polyethylene glycol 400 intestinal permeability by endogenous and exogenous prostanoids. Influence of non-steroidal anti-inflammatory drugs. Issue 4 (April 1990) Authors: Krugliak, P; Hollander, D; Le, K; Ma, T; Dadufalza, V D; Katz, K D Journal: Gut Issue: Volume 31:Issue 4(1990) Page Start: 417 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗